Inventory, Net of BIO-TECHNE Corp from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
BIO-TECHNE Corp quarterly Inventory, Net in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • BIO-TECHNE Corp Inventory, Net for the quarter ending 30 Sep 2025 was $203,188,000, a 9.8% increase year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $203,188,000 +$18,147,000 +9.8% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $189,446,000 +$9,715,000 +5.4% 30 Jun 2025 10-Q 05 Nov 2025 2026 Q1
Q1 2025 $191,083,000 +$11,587,000 +6.5% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $188,373,000 +$7,534,000 +4.2% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $185,041,000 -$1,039,000 -0.56% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $179,731,000 +$8,093,000 +4.7% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $179,496,000 +$10,032,000 +5.9% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $180,839,000 +$20,606,000 +13% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $186,080,000 +$36,071,000 +24% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $171,638,000 +$30,515,000 +22% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $169,464,000 +$41,181,000 +32% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $160,233,000 +$38,375,000 +31% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $150,009,000 +$32,643,000 +28% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $141,123,000 +$24,375,000 +21% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $128,283,000 +$18,293,000 +17% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $121,858,000 +$15,268,000 +14% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $117,366,000 +$11,363,000 +11% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $116,748,000 +$13,596,000 +13% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $109,990,000 +$10,317,000 +10% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $106,590,000 +$11,239,000 +12% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $106,003,000 +$15,148,000 +17% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $103,152,000 +$12,102,000 +13% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $99,673,000 +$5,834,000 +6.2% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $95,351,000 +$4,446,000 +4.9% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $90,855,000 -$63,000 -0.07% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $91,050,000 +$5,402,000 +6.3% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q1 2019 $93,839,000 +$5,253,000 +5.9% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $90,905,000 +$22,625,000 +33% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $90,918,000 +$24,386,000 +37% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $85,648,000 $0 0% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q1 2018 $88,586,000 +$24,819,000 +39% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $68,280,000 +$2,191,000 +3.3% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $66,532,000 -$3,987,000 -5.7% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $85,648,000 +$28,546,000 +50% 30 Jun 2017 10-Q 07 Nov 2018 2019 Q1
Q1 2017 $63,767,000 +$6,701,000 +12% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $66,089,000 +$7,414,000 +13% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $70,519,000 +$11,552,000 +20% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $57,102,000 +$7,525,000 +15% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q1 2016 $57,066,000 +$6,021,000 +12% 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $58,675,000 +$5,860,000 +11% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $58,967,000 +$6,772,000 +13% 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $49,577,000 +$10,730,000 +28% 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q1 2015 $51,045,000 +$12,659,000 +33% 31 Mar 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 $52,815,000 +$12,823,000 +32% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q2
Q3 2014 $52,195,000 +$12,238,000 +31% 30 Sep 2014 10-Q 10 Nov 2014 2015 Q1
Q2 2014 $38,847,000 +$3,970,000 +11% 30 Jun 2014 10-K 31 Aug 2015 2015 FY
Q1 2014 $38,386,000 +$2,711,000 +7.6% 31 Mar 2014 10-Q 12 May 2014 2014 Q3
Q4 2013 $39,992,000 +$2,392,000 +6.4% 31 Dec 2013 10-Q 04 Feb 2014 2014 Q2
Q3 2013 $39,957,000 +$1,560,000 +4.1% 30 Sep 2013 10-Q 12 Nov 2013 2014 Q1
Q2 2013 $34,877,000 -$3,400,000 -8.9% 30 Jun 2013 10-K 29 Aug 2014 2014 FY
Q1 2013 $35,675,000 -$4,822,000 -12% 31 Mar 2013 10-Q 10 May 2013 2013 Q3
Q4 2012 $37,600,000 -$3,378,000 -8.2% 31 Dec 2012 10-Q 11 Feb 2013 2013 Q2
Q3 2012 $38,397,000 -$3,719,000 -8.8% 30 Sep 2012 10-Q 09 Nov 2012 2013 Q1
Q2 2012 $38,277,000 -$6,629,000 -15% 30 Jun 2012 10-K 29 Aug 2013 2013 FY
Q1 2012 $40,497,000 +$26,878,000 +197% 31 Mar 2012 10-Q 10 May 2012 2012 Q3
Q4 2011 $40,978,000 +$27,242,000 +198% 31 Dec 2011 10-Q 07 Feb 2012 2012 Q2
Q3 2011 $42,116,000 +$28,298,000 +205% 30 Sep 2011 10-Q 09 Nov 2011 2012 Q1
Q2 2011 $44,906,000 +$31,169,000 +227% 30 Jun 2011 10-K 29 Aug 2012 2012 FY
Q1 2011 $13,619,000 31 Mar 2011 10-Q 10 May 2011 2011 Q3
Q4 2010 $13,736,000 31 Dec 2010 10-Q 09 Feb 2011 2011 Q2
Q3 2010 $13,818,000 30 Sep 2010 10-Q 09 Nov 2010 2011 Q1
Q2 2010 $13,737,000 30 Jun 2010 10-K 29 Aug 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.